We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stericycle's (SRCL) Stock Gains 6% Post Q4 Earnings Beat
Read MoreHide Full Article
Stericycle, Inc.’s reported mixed fourth-quarter 2023 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.
The stock jumped 6.2% since the release of results on Feb 28 in response to the better-than-expected earnings and impressive guidance.
For 2024, Stericycle expects adjusted earnings per share (EPS) to be between $2.2 and $2.5, the midpoint ($2.35) of which is above the Zacks Consensus Estimate of $2.26.
SRCL’s quarterly EPS (excluding 38 cents from non-recurring items) came in at 54 cents, which surpassed the consensus estimate by 14.9% but declined 10% on a year-over-year basis. Revenues of $652 million missed the consensus mark marginally and declined 2.7% year over year.
The company’s shares have soared 21.4% in the past six months, underperforming the 21.9% rally of the industry it belongs to.
Stericycle, Inc. Price, Consensus and EPS Surprise
Regulated Waste and Compliance Services revenues declined 2.1% from fourth-quarter 2022 but increased 3.1% on an organic basis to $439.9 million, topping our estimated $438.9 million.
Secure Information Destruction revenues decreased 4.1% from the year-ago quarter and 3.6% on an organic basis to $212.1 million, missing our estimate of $218.3 million. This segment's revenues were hurt by declining recycling revenues and lower fuel and environmental fees.
Revenues by Geography
Revenues from North America were $560.1 million, missing our estimate of $560.4 million and down marginally on a year-over-year basis. However, it increased less than 1% organically. International revenues of $91.9 million declined 12.1% from the year-ago quarter but were up 1.3% organically and missed our expectation of $96.9 million.
Profitability Performance
Adjusted EBITDA was $110.3 million, down 6.2% from the year-ago quarter’s figure. Adjusted EBITDA margin was 16.9%, down 60 basis points.
Balance Sheet & Cash Flow
Stericycle exited the quarter with cash and cash equivalents of $35.3 million compared with $29.7 million at the end of the third-quarter of 2023. Long-term debt was $1.3 billion, flat with the preceding quarter. SRCL generated $50 million of net cash from operating activities, while capex was $29.1 million.
2024 Guidance
The company expects 3-5% revenue growth organically. Stericycle expects free cash flow to be between $210 million and $265 million. It anticipates capital expenditures between $140 million and $160 million.
Currently, Stericycle carries a Zacks Rank #3 (Hold).
Republic Services, Inc. (RSG - Free Report) reported an impressive fourth-quarter 2023 results.
RSG’s EPS, excluding 2 cents from non-recurring items, of $1.41 beat the Zacks Consensus Estimate by 10.2% and increased 24.8% year over year. Revenues of $3.8 billion surpassed the consensus mark by 2.9% and increased 8.6% year over year.
Envestnet, Inc. reported impressive fourth-quarter 2023.
ENV’s EPS, excluding $4 from non-recurring items, were 65 cents, surpassing the consensus estimate by 22.6%. The bottom line increased 44.4% from the year-ago quarter. Total revenues of $317.6 million beat the consensus estimate by 1.7%. The top line improved 8.5% on a year-over-year basis.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stericycle's (SRCL) Stock Gains 6% Post Q4 Earnings Beat
Stericycle, Inc.’s reported mixed fourth-quarter 2023 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.
The stock jumped 6.2% since the release of results on Feb 28 in response to the better-than-expected earnings and impressive guidance.
For 2024, Stericycle expects adjusted earnings per share (EPS) to be between $2.2 and $2.5, the midpoint ($2.35) of which is above the Zacks Consensus Estimate of $2.26.
SRCL’s quarterly EPS (excluding 38 cents from non-recurring items) came in at 54 cents, which surpassed the consensus estimate by 14.9% but declined 10% on a year-over-year basis. Revenues of $652 million missed the consensus mark marginally and declined 2.7% year over year.
The company’s shares have soared 21.4% in the past six months, underperforming the 21.9% rally of the industry it belongs to.
Stericycle, Inc. Price, Consensus and EPS Surprise
Stericycle, Inc. price-consensus-eps-surprise-chart | Stericycle, Inc. Quote
Segmental Revenues
Regulated Waste and Compliance Services revenues declined 2.1% from fourth-quarter 2022 but increased 3.1% on an organic basis to $439.9 million, topping our estimated $438.9 million.
Secure Information Destruction revenues decreased 4.1% from the year-ago quarter and 3.6% on an organic basis to $212.1 million, missing our estimate of $218.3 million. This segment's revenues were hurt by declining recycling revenues and lower fuel and environmental fees.
Revenues by Geography
Revenues from North America were $560.1 million, missing our estimate of $560.4 million and down marginally on a year-over-year basis. However, it increased less than 1% organically. International revenues of $91.9 million declined 12.1% from the year-ago quarter but were up 1.3% organically and missed our expectation of $96.9 million.
Profitability Performance
Adjusted EBITDA was $110.3 million, down 6.2% from the year-ago quarter’s figure. Adjusted EBITDA margin was 16.9%, down 60 basis points.
Balance Sheet & Cash Flow
Stericycle exited the quarter with cash and cash equivalents of $35.3 million compared with $29.7 million at the end of the third-quarter of 2023. Long-term debt was $1.3 billion, flat with the preceding quarter. SRCL generated $50 million of net cash from operating activities, while capex was $29.1 million.
2024 Guidance
The company expects 3-5% revenue growth organically. Stericycle expects free cash flow to be between $210 million and $265 million. It anticipates capital expenditures between $140 million and $160 million.
Currently, Stericycle carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot of Peers
Republic Services, Inc. (RSG - Free Report) reported an impressive fourth-quarter 2023 results.
RSG’s EPS, excluding 2 cents from non-recurring items, of $1.41 beat the Zacks Consensus Estimate by 10.2% and increased 24.8% year over year. Revenues of $3.8 billion surpassed the consensus mark by 2.9% and increased 8.6% year over year.
Envestnet, Inc. reported impressive fourth-quarter 2023.
ENV’s EPS, excluding $4 from non-recurring items, were 65 cents, surpassing the consensus estimate by 22.6%. The bottom line increased 44.4% from the year-ago quarter. Total revenues of $317.6 million beat the consensus estimate by 1.7%. The top line improved 8.5% on a year-over-year basis.